ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PDSB vs MGNX // OPERATING MARGIN

PDS Biotechnology Corporation (NASDAQ) VS. MacroGenics Inc. (NASDAQ) • 15-METRIC TALLY: PDSB 2 — MGNX 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PDSB VS. MGNX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PDSB MGNX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 96.00% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -17.05% — — TIE /fcf-yield <GO>
Operating Margin ACTIVE — -48.70% — TIE /operating-margins <GO>
Net Profit Margin — 0.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — -0.30% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 2/9 +1.00 PDSB /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 60.0 32.4 +27.60 PDSB /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $151.2M $152.9M -$1.7M MGNX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PDSB REV MGNX REV PDSB GROSS % MGNX GROSS % PDSB FCF MGNX FCF
FY 2025 $88.3M $149.5M — 98.0% -$27.8M -$83.0M
FY 2024 $101.7M $150.0M — 98.0% -$35.1M -$72.1M
FY 2023 $120.5M $58.7M — — -$33.6M -$78.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PDSB // BETA —
MGNX // BETA —